抗血小板因素4引发免疫血栓形成 - - 不仅仅是肝素和疫苗引发免疫血栓形成
Luisa Müller1, Jing Jing Wang2, Venkata A S Dabbiru1
1Institut für Transfusionsmedizin, Universitätsmedizin Greifswald, Greifswald, Germany.
Research and practice in thrombosis and haemostasis
|April 16, 2025
概括
病理性免疫血栓形成的原因是免疫反应破坏了血液凝固. 本综述详细介绍了抗血小板因子4 (PF4) 抗体疾病,如氨酸诱导的血小板缺血症 (HIT) 和疫苗诱导的免疫血小板缺血症和血栓症 (VITT),包括新的诊断和治疗见解.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 病理学 病理学 病理学
背景情况:
- 免疫血栓形成的原因是血液凝固和先天免疫反应之间的失调.
- 抗血小板因子4 (PF4) 的抗体会导致特定的免疫血栓形成,包括肝素诱导的血栓缩 (HIT) 和疫苗诱导的免疫血栓缩和血栓形成 (VITT).
- 在COVID-19大流行期间最近的VITT病例刺激了对抗PF4抗体疾病的诊断和理解的进步.
研究的目的:
- 提供有关HIT和VITT的当前知识的全面概述.
- 探索抗PF4抗体介导疾病的发病机制.
- 讨论抗PF4抗体综合征的新出现的触发因素和临床表现.
主要方法:
- 对有关HIT,VITT和相关抗PF4抗体疾病的现有文献的综述.
- 分析诊断程序以识别受影响的患者.
- 综合病原遗传概念和临床表现.
主要成果:
- 已知超过50年的HIT涉及由肝素触发的抗PF4抗体.
- 在COVID-19疫苗接种期间出现了VITT病例,突出显示了新的触发因素.
- 非典型的HIT类综合征可以由多种类型 (例如手术,感染),病毒感染或单克隆性骨干病变引起,导致慢性VITT类型疾病.
结论:
- 在患有血小板缺血和/或血栓形成的患者中及时识别抗PF4抗体疾病至关重要.
- 了解各种不同的触发因素和病原遗传机制是有效管理的关键.
- 需要继续进行研究,以完善这些严重疾病的诊断和治疗方法.
相关概念视频
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
548
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
548
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
396
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
396
01:22Formation of the Platelet Plug
3.3K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
3.3K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
4.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
4.2K
01:16Clot Retraction and Fibrinolysis
2.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
2.9K
01:24Disorders of Hemostasis
651
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
651